In Vitro Metabolite Profiling of ADB-FUBINACA, A New Synthetic Cannabinoid.

about

In Vitro Metabolite Profiling of ADB-FUBINACA, A New Synthetic Cannabinoid.

Item

http://www.wikidata.org/entity/Q49227467

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

In Vitro Metabolite Profiling of ADB-FUBINACA, A New Synthetic Cannabinoid.

@en

type

Item

label

In Vitro Metabolite Profiling of ADB-FUBINACA, A New Synthetic Cannabinoid.

@en

prefLabel

In Vitro Metabolite Profiling of ADB-FUBINACA, A New Synthetic Cannabinoid.

@en

P1476

In Vitro Metabolite Profiling of ADB-FUBINACA, A New Synthetic Cannabinoid.

@en

P2093

Ariane Wohlfarth

http://www.w3.org/2001/XMLSchema#string

Jeremy Carlier

http://www.w3.org/2001/XMLSchema#string

Karl Scheidweiler

http://www.w3.org/2001/XMLSchema#string

Xingxing Diao

http://www.w3.org/2001/XMLSchema#string

P2860

Metabolite profiling of RCS-4, a novel synthetic cannabinoid designer drug, using human hepatocyte metabolism and TOF-MS.

Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids.

Schedules of controlled substances: temporary placement of four synthetic cannabinoids into Schedule I. Final order.

UPLC/ESI-MS/MS-based determination of metabolism of several new illicit drugs, ADB-FUBINACA, AB-FUBINACA, AB-PINACA, QUPIC, 5F-QUPIC and α-PVT, by human liver microsome.

Pentylindole/Pentylindazole Synthetic Cannabinoids and Their 5-Fluoro Analogs Produce Different Primary Metabolites: Metabolite Profiling for AB-PINACA and 5F-AB-PINACA

A Common Source Outbreak of Severe Delirium Associated with Exposure to the Novel Synthetic Cannabinoid ADB-PINACA.

Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA.

High-Resolution Mass Spectrometry for Characterizing the Metabolism of Synthetic Cannabinoid THJ-018 and Its 5-Fluoro Analog THJ-2201 after Incubation in Human Hepatocytes.

Death Associated With the Use of the Synthetic Cannabinoid ADB-FUBINACA.

Human hepatocytes: isolation, cryopreservation and applications in drug development.

P304

682-691

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1570159X15666161108123419

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marilyn Huestis

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29403341

http://www.w3.org/2001/XMLSchema#string

P921

cannabinoids

P932

5771045

http://www.w3.org/2001/XMLSchema#string